ATE387449T1 - Pyrazolopyrimidine - Google Patents

Pyrazolopyrimidine

Info

Publication number: ATE387449T1
Authority: AT; Austria
Prior art keywords: pyrazolopyrimidines; compounds; formula; relates
Prior art date: 2003-11-24

Application number

AT04798915T

Other languages

English (en)

Inventor

Andrew Bell

David Brown

David Bull

David Fox

Ian Marsh

Andrew Morrell

Michael Palmer

Carol Winslow

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-24

Filing date

2004-11-19

Publication date

2008-03-15

2004-11-19 Application filed by Pfizer filed Critical Pfizer

2008-03-15 Application granted granted Critical

2008-03-15 Publication of ATE387449T1 publication Critical patent/ATE387449T1/de

Links

150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT04798915T 2003-11-24 2004-11-19 Pyrazolopyrimidine ATE387449T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0327323.2A GB0327323D0 (en)	2003-11-24	2003-11-24	Novel pharmaceuticals

Publications (1)

Publication Number	Publication Date
ATE387449T1 true ATE387449T1 (de)	2008-03-15

Family

ID=29797726

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04798915T ATE387449T1 (de)	2003-11-24	2004-11-19	Pyrazolopyrimidine

Country Status (11)

Country	Link
US (1)	US20070105877A1 (de)
EP (1)	EP1689752B1 (de)
JP (1)	JP2007512317A (de)
AT (1)	ATE387449T1 (de)
BR (1)	BRPI0416678A (de)
CA (1)	CA2545196A1 (de)
DE (1)	DE602004012146T2 (de)
ES (1)	ES2300849T3 (de)
GB (1)	GB0327323D0 (de)
MX (1)	MXPA06005824A (de)
WO (1)	WO2005049617A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7951805B2 (en)	2004-09-20	2011-05-31	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1804799B1 (de)	2004-09-20	2013-08-21	Xenon Pharmaceuticals Inc.	Heterozyklische Derivate und ihre Verwendung als Stearoyl-Coa-Desaturase-Inhibitoren
EP2289510A1 (de)	2004-09-20	2011-03-02	Xenon Pharmaceuticals Inc.	Heterozyklische Derivate zur Behandlung von durch Stearoyl-Coa-Desaturase-Enzyme verursachten Krankheiten
CA2580856A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2316458A1 (de)	2004-09-20	2011-05-04	Xenon Pharmaceuticals Inc.	Pyridazin-Derivate zur Verhinderung menschlicher Stearoyl-coa-desaturas
EP1799667B1 (de)	2004-09-20	2013-03-20	Xenon Pharmaceuticals Inc.	Heterozyklische derivate und ihre verwendung als therapeutische wirkstoffe
US7767677B2 (en)	2004-09-20	2010-08-03	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
PT1881985E (pt)	2005-05-12	2011-02-01	Pfizer	Formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n- -etil-n-metilamino)-7-(4-metilpiridin-2-il-amino)-1h- -pirazolo[4,3-d]pirimidino-3-carbonil]metanossulfonamida
EP2029138A1 (de)	2005-06-03	2009-03-04	Xenon Pharmaceuticals Inc.	Aminothiazolderivate als humane stearoyl-coa desaturasehemmer
NL2000291C2 (nl)	2005-11-10	2009-02-17	Pfizer Prod Inc	1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
WO2014039421A1 (en) *	2012-09-04	2014-03-13	Celgene Corporation	Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
CN109996546B (zh)	2016-09-30	2023-06-27	阿沙纳生物科学公司	P2x3和/或p2x2/3化合物及方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3951980A (en) *	1974-05-09	1976-04-20	Stanford Research Institute	3-Substituted-8-methyl-3,8-diazabicyclo[3.2.1]octanes
US4282361A (en) *	1978-03-16	1981-08-04	Massachusetts Institute Of Technology	Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines
US5091431A (en) *	1988-02-08	1992-02-25	Schering Corporation	Phosphodiesterase inhibitors
US5442044A (en) *	1991-01-04	1995-08-15	Pfizer Inc.	Orally active renin inhibitors
US5869486A (en) *	1995-02-24	1999-02-09	Ono Pharmaceutical Co., Ltd.	Fused pyrimidines and pyriazines as pharmaceutical compounds
GB9518953D0 (en) *	1995-09-15	1995-11-15	Pfizer Ltd	Pharmaceutical formulations
DE19644228A1 (de) *	1996-10-24	1998-04-30	Merck Patent Gmbh	Thienopyrimidine
US6184338B1 (en) *	1997-08-27	2001-02-06	Fmc Corporation	Anionic polymerization initiators containing tertiary amine functionality, their chain extended analogues, and processes for using the same
HU227841B1 (en) *	1997-11-12	2012-05-02	Bayer Pharma AG	2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
CA2367130A1 (en) *	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
US6465486B1 (en) *	1999-03-12	2002-10-15	Ortho-Mcneil Pharmaceutical, Inc.	Pyridyl/quinolinyl imidazoles
DE19942474A1 (de) *	1999-09-06	2001-03-15	Merck Patent Gmbh	Pyrazolo[4,3-d]pyrimidine
US6548509B2 (en) *	1999-10-22	2003-04-15	Neurogen Corporation	3-aryl substituted pyrazolo[4,3-D]pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
US20030187261A1 (en) *	2000-01-07	2003-10-02	Libor Havlicek	Purine derivatives, process for their preparation and use thereof
US20010047013A1 (en) *	2000-03-10	2001-11-29	Fengrui Lang	Process for the preparation of arylamines
DE10031584A1 (de) *	2000-06-29	2002-01-10	Merck Patent Gmbh	5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) *	2000-11-25	2002-05-29	Merck Patent Gmbh	Verwendung von Pyrazolo[4,3-d]pyrimidinen
BR0115995A (pt) *	2000-12-19	2004-01-13	Merck Patent Gmbh	Formulação farmacêutica compreendendo pirazolo[4,3-d]pirimidinas e antitrombóticos, antagonistas de cálcio, prostaglandinas ou derivados de prostaglandina
US20020127593A1 (en) *	2001-03-12	2002-09-12	Regents Of The University Of California	Fluorescence assay for DNA modifying enzymes
PE20030008A1 (es) *	2001-06-19	2003-01-22	Bristol Myers Squibb Co	Inhibidores duales de pde 7 y pde 4
US6432957B1 (en) *	2001-06-29	2002-08-13	Kowa Co., Ltd.	Piperazine derivative
ATE478872T1 (de) *	2002-03-28	2010-09-15	Ustav Ex Botan Av Cr V V I I O	Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
KR100824193B1 (ko) *	2003-04-29	2008-04-21	화이자 인코포레이티드	고혈압 치료에 유용한5,7-디아미노피라졸로[4,3-ｄ]피리미딘

2003
- 2003-11-24 GB GBGB0327323.2A patent/GB0327323D0/en not_active Ceased
2004
- 2004-11-19 JP JP2006540655A patent/JP2007512317A/ja not_active Withdrawn
- 2004-11-19 EP EP04798915A patent/EP1689752B1/de not_active Expired - Lifetime
- 2004-11-19 MX MXPA06005824A patent/MXPA06005824A/es active IP Right Grant
- 2004-11-19 AT AT04798915T patent/ATE387449T1/de not_active IP Right Cessation
- 2004-11-19 CA CA002545196A patent/CA2545196A1/en not_active Abandoned
- 2004-11-19 WO PCT/IB2004/003791 patent/WO2005049617A1/en not_active Ceased
- 2004-11-19 BR BRPI0416678-7A patent/BRPI0416678A/pt not_active IP Right Cessation
- 2004-11-19 DE DE602004012146T patent/DE602004012146T2/de not_active Expired - Fee Related
- 2004-11-19 ES ES04798915T patent/ES2300849T3/es not_active Expired - Lifetime
- 2004-11-19 US US10/580,306 patent/US20070105877A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE602004012146T2 (de)	2009-03-19
CA2545196A1 (en)	2005-06-02
JP2007512317A (ja)	2007-05-17
GB0327323D0 (en)	2003-12-31
US20070105877A1 (en)	2007-05-10
ES2300849T3 (es)	2008-06-16
MXPA06005824A (es)	2006-08-11
BRPI0416678A (pt)	2007-02-13
WO2005049617A1 (en)	2005-06-02
EP1689752A1 (de)	2006-08-16
EP1689752B1 (de)	2008-02-27
DE602004012146D1 (en)	2008-04-10

Legal Events

Date	Code	Title	Description
2008-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60230890D1 (de)	2009-03-05	Indolizine als kinaseproteinhemmer
CY1110933T1 (el)	2015-06-10	5,7-διαμινοπυραζολο[4,3-d]πυριμιδινες με ανασταλτικη της pde-5 δραστικοτητα
ATE384061T1 (de)	2008-02-15	Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren
UY29612A1 (es)	2007-01-31	Compuestos quimicos ii
ATE365740T1 (de)	2007-07-15	Substituierte pyrazolopyrimidine
DE60309848D1 (de)	2007-01-04	Purinderivate als kinaseinhibitoren
UY28290A1 (es)	2004-11-30	Compuestos farmacéuticos novedosos
EA201790678A1 (ru)	2017-12-29	Бициклические гетероарильные соединения
EA200700188A1 (ru)	2007-06-29	Производные замещенного 2-алкилхиназолинона как ингибиторы parp
EA200700185A1 (ru)	2007-06-29	Производные хиназолиндиона в качестве ингибиторов parp
CY1106132T1 (el)	2011-06-08	Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CY1105386T1 (el)	2010-04-28	Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
EA200601007A1 (ru)	2006-10-27	7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
BRPI0510177B8 (pt)	2021-05-25	composto, composição farmacêutica e uso do mesmo
NO20071127L (no)	2007-02-28	Triazoloftalaziner
EA200801608A1 (ru)	2008-10-30	Производные бензимидазолонкарбоновой кислоты
ATE400567T1 (de)	2008-07-15	Kinaseinhibitoren
CY1106247T1 (el)	2011-06-08	Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
GB0127903D0 (en)	2002-01-16	Improvements relating to organic compounds
EA200601515A1 (ru)	2006-12-29	Пиразолопиримидины для борьбы с нежелательными микроорганизмами
ATE375978T1 (de)	2007-11-15	Benzoylsulfonamide als antitumor-mittel
DE602004012146D1 (en)	2008-04-10	Pyrazolopyrimidine
EA201000566A1 (ru)	2010-12-30	Гетероциклические сетр ингибиторы
DOP2005000010A (es)	2005-11-15	Inhibidores de quinasa
DK1742950T3 (da)	2009-03-16	Pyrazolo-[4,3-D]-pyrimidiner